Craft

Esperite

Stock Price

$15.5

2023-10-12

Market Capitalization

$38.3 M

2023-10-12

Revenue

€11.8 M

FY, 2018

Esperite Summary

Company Summary

Overview
Esperite is a company specializing in regenerative and predictive medicine. It operates through Cryo-Save, The Cell Factory, Genoma, and Stem Cell segments. The company collects, processes, and preserves stem cell samples from umbilical cord blood and cord tissue. Besides, Esperite markets tests on sequencing and genomics, develops a diagnostic system AGAATA based on the Next Generation Sequencing technology (NGS), provides proteomics and genomics predictive medicines, etc.
Type
Public
Status
Active
Founded
2000
HQ
Amsterdam, NL | view all locations
Website
https://www.esperite.com/
Cybersecurity rating
Sectors

Key People

  • Frédéric Amar

    Frédéric Amar, Executive Director and CEO

    • Ronald Lorijn

      Ronald Lorijn, Non-Executive Director

      • Vincent Borgeot

        Vincent Borgeot, Non-Executive Director

        LocationsView all

        2 locations detected

        • Amsterdam, NH HQ

          Netherlands

          Herengracht 282

        • Villeurbanne, Auvergne-Rhône-Alpes

          France

          35 Rue Louis Guérin

        Esperite Financials

        Summary Financials

        Revenue (FY, 2018)
        €11.8M
        Gross profit (FY, 2018)
        €7.5M
        Net income (FY, 2018)
        (€18.5M)
        Cash (FY, 2018)
        €775.0K
        EBIT (FY, 2018)
        (€18.9M)
        Enterprise value
        $48.5M

        Footer menu